Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
![Foto de Grupo de Investigación en Cáncer de Mama](/img/uploaded/46084eb269a9135ee7dc8a58bb36982a.jpg)
![Foto de Clínica Universitaria de Navarra](/img/noimage_org.png)
Clínica Universitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (118)
2024
-
Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer
Seminars in Oncology Nursing, Vol. 40, Núm. 1
-
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)
European Journal of Nuclear Medicine and Molecular Imaging
-
Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line
Clinical and Translational Oncology
2023
-
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry
European Journal of Surgical Oncology, Vol. 49, Núm. 10
-
Osteoclast-rich undifferentiated carcinoma of the bladder and the diagnostic usefulness of immunohistochemistry. A case report
Revista Espanola de Patologia, Vol. 56, Núm. 2, pp. 132-135
2022
-
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer
Cancer Discovery, Vol. 12, Núm. 5, pp. 1356-1377
2020
-
Axillary staging based on molecular analysis: Results of the B-CLOSER-II study
Pathology Research and Practice, Vol. 216, Núm. 11
-
Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)
Gynecologic Oncology Reports, Vol. 33
-
Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals
Frontiers in Oncology, Vol. 10
-
Incidental lesions of the pancreas. A clinicopathological study of 100 cases surgically treated
Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 2, pp. 85-89
-
The accuracy of titanium contrast-enhanced mammography: a retrospective multicentric study
Acta Radiologica, Vol. 61, Núm. 10, pp. 1335-1342
2019
-
Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach
British Journal of Clinical Pharmacology, Vol. 85, Núm. 8, pp. 1670-1683
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
-
Is it worth to perform preoperative MRI for breast cancer after mammography, tomosynthesis and ultrasound?
Magnetic Resonance Imaging, Vol. 57, pp. 317-322
-
Programmed death–ligand 1 expression on direct Pap-stained cytology smears from non–small cell lung cancer: Comparison with cell blocks and surgical resection specimens
Cancer Cytopathology, Vol. 127, Núm. 7, pp. 470-480
-
Pruritic Primary Nonessential Cutis Verticis Gyrata
Actas Dermo-Sifiliograficas, Vol. 110, Núm. 8, pp. 702-704
2018
-
Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey
European Journal of Surgical Oncology, Vol. 44, Núm. 2, pp. 228-236
-
Erratum: Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial (Brachytherapy (2018) 17(5) (734–741), (S1538472118300898) (10.1016/j.brachy.2018.04.007))
Brachytherapy
-
Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial
Brachytherapy, Vol. 17, Núm. 5, pp. 734-741
2017
-
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Journal of Translational Medicine, Vol. 15, Núm. 1